Genesis Biosciences European facility completes successful ISO 14001 surveillance audit

The Genesis Biosciences European facility was first approved for certification against ISO 14001:2004 in February 2013.  Surveillance assessments are the heart of the post-certification process for ISO 14001 certification and Genesis Bioscience are subject to these audits on an annual basis. 

In February 2014 the company was audited against the standard by SGS (a leading provider of certification services) and the audit was completed with no corrective actions raised. 

“The successful surveillance audit shows that Genesis Biosciences continues to be committed to its environmental objectives” stated Debbie Williams the European Operations Manager who is also responsible for company quality management standards globally.